Approved Medicare & Medicaid Providers

1-888-876-3363

Why Choose US MED?

US MED is Accredited by the Better Business Bureau.

100% Satisfaction Guaranteed.

Approved Medicare & Medicaid Providers.

Contracted with over 500 national private insurance plans. 

Free shipping delivered right
to your door.

Diabetes specialists ready to answer your questions.

Take Control of Your Diabetes With a CGM System

• Easily view your glucose levels by glancing at your CGM’s reader or compatible smartphone.*  
• Set your own glucose alerts to notify you before you are too high or too low.  
• Understand how meals, exercise, and illness impact your blood glucose levels.
• Share your glucose data with your doctor, family member, or caretaker remotely.

We Carry The Latest In CGM Technology

Dexcom G7

Dexcom’s tiniest sensor yet - 60% smaller than the G6.

Unmatched accuracy^† and warmup speed^††

Compatible with a
fully-redesigned app.^¶

Approved for people with diabetes aged 2 years and older.

FreeStyle Libre 3 Plus Sensor

Experience the most advanced 15-day sensor with 6 sensors per 90 days. Approved for people with diabetes aged 2 years and older, including during pregnancy. 

With the brand-new Freestyle Libre 3, get readings every minute. That's 1,440 readings per day. 

The world’s smallest, thinnestII, and most discreetII, sensor—smaller than two stacked pennies.

See What Our Customers are Saying

See if you qualify for a Continuous Glucose Monitor 

or call us today! 1-888-876-3363

Take control of your diabetes journey with US MED. We offer comprehensive support, medical equipment, and the knowledge to help you thrive. 

* Use a blood glucose meter to confirm any highs or lows and when your symptoms do not match your sensor’s readings.

** In a trial where Dexcom G6 powered the Tandem hybrid closed-loop system with Control-IQ, participants with T1D increased their time in range (TIR) by an average of 2+ hours per day. - Kovatchev B, et al. N Engl J Med 2019;381(18):1707-17. Individual results may vary.

† Reduction of A1C by 1.0% for Patients with T1D. Dexcom CGM System users on a multiple daily injections (MDI) insulin regimen showed an average A1C reduction of 1% after 24 weeks of regular use, compared to baseline. Additionally, 52% of subjects in the study had a ≥1% A1C reduction. Beck RW, et al. JAMA. 2017;317(4):371-378. Significant A1C reduction for patients with T2D on mealtime insulin achieved an average 1.5% A1C reduction after using Dexcom G6 for 12+ weeks. Noar A, et al. A1C reductions and improved patient-reported outcomes following CGM initiation in insulin-managed T2D. Presented at ADA 80th Scientific Sessions; June 12, 2020; Virtual. Individual results may vary.

‡ Check glucose levels up to 1,440 times per day on the FreeStyle Libre 2 System

1 For qualified persons with applicable in-network insurance and subject to CGM coverage requirements. Deductibles, co-pays, and other conditions apply. Speak to a US MED representative and your insurance company to confirm your coverage and costs. CGM devices have safety requirements, warnings, and instructions. Consult the manufacturer websites for details. Seek medical advice and attention when appropriate, including for any medical emergency.

§ Satisfaction Guarantee is for US MED services. Products must be returned unopened within 30 days for any refunds. Other terms and conditions apply. Visit www.USMED.com/return-policy for full details. Product warranties are provided by manufacturer and subject to their terms and conditions.

United States Medical Supply, LLC | Privacy Policy | www.usmed.com
US MED | 8200 NW 33^rd Street, Suite 200 Doral, Fl. 33122
Copyright © 2024 US Medical Supply. All Rights Reserved

Easily view your glucose levels by glancing at your CGM’s reader or compatible smartphone.* 

Set your own glucose alerts to notify you before you are too high or too low.

 Understand how meals, exercise, and illness impact your blood glucose levels.

Share your glucose data with your doctor, family member, or caretaker remotely.